ECOG PCO-RL: E5103: A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Bevacizumab or Placebo in Patients with Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer

Project: Research project

Project Details

Effective start/end date11/2/0712/31/15


  • Frontier Science and Technology Research Foundation (PCOE5103-00)
  • Genentech, Inc. (PCOE5103-00)